Stay updated on TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.

Latest updates to the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe new page shows minor UI/layout adjustments to headings and formatting; there are no changes to core study data such as eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check31 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check39 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check53 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.SummaryDifference0.1%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

- Check68 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, while removing several previous location entries. Notably, the revision number has been updated to v3.0.0.SummaryDifference4%

Stay in the know with updates to TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.